Skip to main content
IRTC
NASDAQ Industrial Applications And Services

iRhythm Holdings Reports First-Ever Quarterly GAAP Net Income and Positive Annual Free Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$160.5
Mkt Cap
$5.119B
52W Low
$92.52
52W High
$212
52W Position info
73% above low
Off High info
24% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

IRTC sits 73% above its 52-week low of $92.52.

Summary

iRhythm Holdings, Inc. announced strong fourth quarter and full year 2025 financial results, achieving its first quarter of positive GAAP net income and first year of positive free cash flow in company history, alongside robust revenue growth and improved margins.


Key Events · Earnings and Guidance · IRTC

  • Record Q4 Revenue

    Reported $208.9 million in revenue for Q4 2025, a 27.1% increase compared to the fourth quarter of 2024.

  • First Positive GAAP Net Income

    Achieved net income of $5.6 million in Q4 2025, marking the first quarter of positive GAAP net income in company history.

  • First Positive Annual Free Cash Flow

    Generated $34.5 million in free cash flow for the full year 2025, the first time the company has achieved positive annual free cash flow.

  • Strong Full Year Performance

    Full year 2025 revenue grew 26.2% to $747.1 million, with significant improvements in gross margin and adjusted EBITDA.


Analysis · IRTC · Industrial Applications And Services

This 8-K filing is highly significant as it reports iRhythm Holdings' achievement of key financial milestones: the first quarter of positive GAAP net income and the first full year of positive free cash flow. These accomplishments, coupled with strong revenue growth of over 26% for both the quarter and full year 2025, demonstrate a fundamental improvement in the company's operational efficiency and business model durability. The improved gross margins and adjusted EBITDA further underscore this positive trend. The provided 2026 guidance for continued revenue growth and adjusted EBITDA margin expansion suggests management's confidence in sustaining this positive momentum. Investors should view these results as a strong indicator of the company's maturation and ability to generate sustainable profitability.

At the time of this filing, IRTC was trading at $160.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.1B. The 52-week trading range was $92.52 to $212.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IRTC - Latest Insights

IRTC
Jul 03, 2026, 12:38 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $126.48
Real-time Price: $117.37 info
Change: -$9.11 (-7%) info
Market Cap: $3.857B info
IRTC
Jun 15, 2026, 6:52 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $113.76
Real-time Price: $117.37 info
Change: +$3.61 (+3%) info
Market Cap: $3.857B info
IRTC
Jun 15, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $113.76
Real-time Price: $117.37 info
Change: +$3.61 (+3%) info
Market Cap: $3.857B info
IRTC
Jun 05, 2026, 7:47 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $107.33
Real-time Price: $117.37 info
Change: +$10.04 (+9%) info
Market Cap: $3.857B info
IRTC
May 01, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $120.80
Real-time Price: $117.37 info
Change: -$3.43 (-3%) info
Market Cap: $3.857B info